Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:552-557

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lembo, G.
Right arrow Articles by Trimarco, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lembo, G.
Right arrow Articles by Trimarco, B.
Related Collections
Right arrow Other hypertension
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2000;102:552.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Noradrenergic Vascular Hyper-Responsiveness in Human Hypertension Is Dependent on Oxygen Free Radical Impairment of Nitric Oxide Activity

Presented in part at the 52nd Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research, Philadelphia, Penn, September 15–18, 1998.

Giuseppe Lembo, MD, PhD; Carmine Vecchione, MD; Raffaele Izzo, MD; Luigi Fratta, MD; Dario Fontana, MD; Gennaro Marino, MD; Giovanni Pilato, MD; Bruno Trimarco, MD

From Istituto di Ricovera e Cura a Carattere Scientifico Neuromed, Pozzilli (G.L., C.V., L.F., B.T.) and the Department of Internal Medicine (R.I., D.F., G.M., G.P., B.T.), "Federico II" University of Naples, Italy.

Correspondence to Giuseppe Lembo, MD, PhD, IRCCS Neuromed, Località Camerelle, 86077 Pozzilli (IS), Italy. E-mail lembo{at}neuromed.it

Background—Noradrenergic vascular hyper-responsiveness is a hallmark of essential hypertension. To evaluate whether nitric oxide plays a role in the enhanced vascular response to norepinephrine in hypertension, we examined 32 hypertensives and 28 normotensives who were distributed in 3 experimental series.

Methods and Results—In the first series, we measured the forearm blood flow (FBF) response to a norepinephrine infusion under control conditions and during the infusion of L-N-monomethylarginine (L-NMMA). Norepinephrine evoked dose-dependent vasoconstriction that was greater in hypertensives than in normotensives (maximum FBF, -61±1 versus -51±1%; P<0.01). During L-NMMA infusion, norepinephrine vasoconstriction was not modified in hypertensives; however, it was potentiated in normotensives (maximum FBF, -64±2%; P<0.01). In the second series, we tested whether norepinephrine vasoconstriction could be affected by an antioxidant such as ascorbic acid. Norepinephrine vasoconstriction was blunted by ascorbic acid administration only in hypertensives (maximum FBF, -49±3 versus -63±2%; P<0.01); the vasoconstriction became similar to that observed in normotensives. During ascorbic acid plus L-NMMA administration, the vascular response to norepinephrine increased to a similar extent in both study groups. To rule out the possibility that the effect of ascorbic acid on norepinephrine vasoconstriction could depend on adrenergic receptor–induced nitric oxide release, in the last series we inhibited endogenous nitric oxide and replaced it with an exogenous nitric oxide donor (sodium nitroprusside). Even in these conditions, ascorbic acid attenuated norepinephrine vasoconstriction only in hypertensives (maximum FBF, -50±2 versus -62±1%; P<0.01).

Conclusions—Our data demonstrate that noradrenergic vascular hyper-responsiveness in hypertension is dependent on an impairment of nitric oxide activity that is realized through norepinephrine-induced oxygen free radical production.


Key Words: norepinephrine • hypertension • blood flow • endothelium • antioxidants




This article has been cited by other articles:


Home page
J. Physiol.Home page
E. G. Smith, W. F. Voyles, B. S. Kirby, R. R. Markwald, and F. A. Dinenno
Ageing and leg postjunctional {alpha}-adrenergic vasoconstrictor responsiveness in healthy men
J. Physiol., July 1, 2007; 582(1): 63 - 71.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. L. Kolo, T. C. Westfall, and H. Macarthur
Modulation of neurotransmitter release by NO is altered in mesenteric arterial bed of spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1842 - H1847.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. A. Dinenno, N. M. Dietz, and M. J. Joyner
Aging and Forearm Postjunctional {alpha}-Adrenergic Vasoconstriction in Healthy Men
Circulation, September 10, 2002; 106(11): 1349 - 1354.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Chen, R. M. Touyz, J. B. Park, and E. L. Schiffrin
Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR
Hypertension, September 1, 2001; 38(3): 606 - 611.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. D. Brook, J. R. Brook, B. Urch, R. Vincent, S. Rajagopalan, and F. Silverman
Inhalation of Fine Particulate Air Pollution and Ozone Causes Acute Arterial Vasoconstriction in Healthy Adults
Circulation, April 2, 2002; 105(13): 1534 - 1536.
[Abstract] [Full Text] [PDF]